Equity funding options for issuers in light of the COVID-19 pandemic

Many companies listed on the Main Market of the London Stock Exchange and quoted on AIM are facing an unprecedented cash flow crisis which may require them to raise capital as a result of the financial impact of the COVID-19 pandemic and fluctuating share prices. We have prepared a short summary table that sets out an overview of the advantages and disadvantages of a selection of equity funding options for issuers to consider.